Key result
Coronary Sinus Reducer linked to ~3-point increase in RV fractional area change in RV dysfunction.
Observational (n=25)
Open-label
No
Answers are grounded in this paper and cite their sources.
May improve RV function in patients with baseline dysfunction; leaves open need for randomized confirmation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mann et al. (2022) conducted an observational in Obstructive coronary artery disease and refractory angina (n=25). Coronary Sinus Reducer device implantation vs. Baseline (pre-implantation) was evaluated on Right ventricular fractional area change (RV FAC) in patients with baseline RV dysfunction (p=0.033). Coronary Sinus Reducer implantation improved RV fractional area change from 34.1% to 36.7% and S' from 8 to 9.5 cm/s in patients with baseline RV dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: